Our team of experts specializes in delivering fast turnarounds and handling large, complex PK/PD datasets. Over 60% of our work focuses on complicated studies, such as oncology, with ample experience in immunology, infectious, cardiovascular, rheumatology, neurology and other diseases. Additionally, we have extensive experience in various clinical pharmacology studies, including single ascending dose (SAD), multiple ascending dose (MAD), drug-drug interaction, and hepatic/renal impairment studies. We are recognized for our accuracy and integrity, and strong commitment for client satisfaction. With decades of experience across various types of drug candidates, matrices, and therapeutic areas at every phase of development, we deliver high-quality results and make swift, reliable decisions to meet timelines. At the same time, we remain highly flexible to easily accommodating additional requests. Each PK/PD analysis is performed by competent and qualified staff, according to high-quality GCP based Standard Operating Procedures (SOPs) using validated software, like Phoenix WinNonLin, SAS, and R. To ensure the highest standards, all data and calculations are independently checked for quality before the report is peer reviewed internally.